TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
Qifang Zhang(Guiyang Medical University), Marcin Kortylewski(City of Hope)
Cited by 109
Related Papers
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
|Nature Medicine|2010|395
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
|Nature Biotechnology|2009|378
Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity
|Journal of Clinical Investigation|2020|82
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
|Molecular Therapy — Nucleic Acids|2024|31
Contributors
|Elsevier eBooks|2022|0